^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: CLL/SLL With del(17p)/TP53 Mutation...Useful in Certain Circumstances...Obinutuzumab…